UW-Madison said reductions in NIH funding will "ultimately harm the livelihoods of real people across Wisconsin and the ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for his first injection of an experimental drug called ...

In a novel theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the ...

Scientists used high-resolution 3D X-ray imaging to uncover major structural and immune changes in the gut of Alzheimer's ...

Delayed REM sleep may be linked to a higher risk of Alzheimer’s disease, new research found. Here's how to build a healthy ...

A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and ...

A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

Are concerns about sleeping pills being linked to dementia based on evidence? Many people need help getting to, or staying, ...

Ian Randall is Newsweek's Deputy Science Editor, based in Royston, U.K. His focus is reporting on science and health. He has covered archeology, geology, and physics extensively. Ian joined ...